LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Fr532 THE EFFECT OF GUSELKUMAB INDUCTION THERAPY ON INFLAMMATORY BIOMARKERS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: WEEK 12 RESULTS FROM THE PHASE 2 GALAXI 1 STUDY

Photo from wikipedia

1Icahn School of Medicine at Mount Sinai, New York, USA; 2Humanitas Research Hospital, Milan, Italy; 3Royal Adelaide Hospital, Adelaide, Australia, 4Janssen Research & Development, LLC, Spring House, PA, USA; 5University… Click to show full abstract

1Icahn School of Medicine at Mount Sinai, New York, USA; 2Humanitas Research Hospital, Milan, Italy; 3Royal Adelaide Hospital, Adelaide, Australia, 4Janssen Research & Development, LLC, Spring House, PA, USA; 5University of Calgary, Calgary, AB, Canada; 6 University of Malaya, Kuala Lumpur, Malaysia; 7 The Ohio State University Wexner Medical Center, Columbus, OH, USA; 8University of California San Diego, La Jolla, CA, USA

Keywords: inflammatory biomarkers; effect guselkumab; therapy inflammatory; guselkumab induction; fr532 effect; induction therapy

Journal Title: Gastroenterology
Year Published: 2021

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.